. 2022 May 29;13(5):13162–13173. doi: 10.1080/21655979.2022.2074109
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 2.
Sitagliptin prevented H/R-induced damages in H9c2 cardiomyocytes.